MGMT and glioblastoma: This reduction in MGMT transcription levels, prompted by LB-100, could be advantageous for glioblastoma patients, as the absence of MGMT expression is regarded as a favorable prognostic indicator for temozolomide-treated glioblastoma patients [52].